1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAREPTA THERAPEUTICS INC

Sarepta Therapeutics Inc

XNAS: SRPT

Falling Comet
Download real time

73.45 -6.52 (-8.15%)

New 52W Low today

3.6M XNAS Volume

High vol.+loss this week

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
12S
14W
0O
3T
7,127

Market Cap

High in industry
30.3

PE TTM

High in industry
0.2

PEG TTM

PEG TTM is less than 1
4.7

Price to Book

Below industry Median
0.5

Beta 1Year

Very Low volatility
Treatment Failure
Sarepta plunges on Tuesday as a patient treated with its gene therapy died from acute liver failure See details

Sarepta Therapeutics Inc - SRPT - stock price prediction, stock price target, analyst ratings from 24 analysts

Sarepta Therapeutics Inc has a share price target of US$ 172, revenue growth forecast of 64.9%, and profit growth estimate of 284.1% for FY25, based on top 24 analyst calls.

Forecaster Screeners